Physician profile
Ashley Nacole Cooper
NPI 1548783509
$1,541.23
in general payments reported to CMS, 2019-2025
15 companies · $347 in 2025
The $347 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $80.59 · 2022: $263 · 2023: $513 · 2024: $338 · 2025: $347.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,190 · Education: $8.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,189.69 |
| Education | $8.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $355.84 | 2021-2025 | |
| Lundbeck LLC | $247.38 | 2021-2025 | Rexulti |
| Otsuka America Pharmaceutical, INC. | $209.99 | 2021-2024 | Rexulti, Abilify Maintena |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $148.15 | 2024-2025 | Caplyta |
| Corium, LLC | $92.61 | 2022-2025 | Azstarys |
| Vanda Pharmaceuticals INC. | $90.42 | 2022-2025 | Fanapt, Hetlioz |
| Tris Pharma INC | $86.73 | 2023-2024 | Dyanavel Xr |
| Ironshore Pharmaceuticals INC. | $82.07 | 2022-2023 | Jornay Pm |
| Axsome Therapeutics, INC. | $71.92 | 2025 | Auvelity |
| Supernus Pharmaceuticals, INC. | $46.42 | 2024-2025 | Qelbree |
| Takeda Pharmaceuticals U.S.A., INC. | $32.78 | 2023-2024 | Trintellix |
| Organogenesis INC. | $21.31 | 2022 | |
| Collegium Pharmaceutical, INC. | $21.16 | 2025 | Jornay Pm |
| E.R. Squibb & Sons, L.L.C. | $20.71 | 2025 | Cobenfy |
| Neuronetics, INC. | $13.74 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Cooper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.